Filing Details

Accession Number:
0001225208-16-025767
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-08 12:38:13
Reporting Period:
2016-02-04
Filing Date:
2016-02-08
Accepted Time:
2016-02-08 12:38:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1025355 W Wesley Schack Von One Edwards Way
Irvine CA 92614
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-02-04 8,106 $83.23 40,130 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,652 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $83.18 to $83.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  2. These shares were previously reported as directly owned and are now being reported as indirectly owned. On December 11, 2015, the common stock of the Issuer split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  3. The von Schack Revocable Trust
  4. Excludes shares that were previously reported as directly owned and are now being reported as indirectly owned. On December 11, 2015, the common stock of the Issuer split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.